Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,131,892
-$1,578,282 QoQ
Shares Held
9,834
-1.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#364
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Norinchukin Bank, The holds $23,476,207 across 6 Biotechnology names. REGN ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,275 | $12,554,850 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
9,834 | $6,131,892 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,171 | $1,556,626 | |
| 4 | MRNA |
Moderna, Inc.
|
21,383 | $1,497,451 | |
| 5 | INCY |
Incyte Corp
|
9,401 | $1,065,697 | |
| 6 | TECH |
BIO-TECHNE Corp
|
9,479 | $669,691 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,131,892 | 9,834 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,710,174 | 9,979 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,434,651 | 9,632 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,954,160 | 8,811 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,805,850 | 9,154 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,313,578 | 8,378 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,138,637 | 5,810 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,608,365 | 5,335 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,837,891 | 4,603 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,399,541 | 4,571 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,134,111 | 4,707 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,423,410 | 5,375 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,893,161 | 10,985 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,915,996 | 8,417 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,913,332 | 8,196 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,925,898 | 10,054 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,365,687 | 9,077 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $7,707,763 | 11,036 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $6,296,885 | 9,971 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $6,355,600 | 10,502 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $5,521,726 | 9,886 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,615,953 | 9,756 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,488,575 | 9,291 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,207,073 | 9,302 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,421,389 | 8,693 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,442,444 | 7,050 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||